Inventiva (IVA) Non-Current Assets (2018 - 2025)

Inventiva's (IVA) quarterly Non-Current Assets came in at $5.9 million in Q4 2025, down 99.93% year-on-year from $8.0 billion in Q4 2024, and down 99.92% quarter-over-quarter from $7.0 billion in Q2 2025.

Inventiva (IVA) Non-Current Assets (2018 - 2025) Analysis & Trends

Inventiva's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.9 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 99.93% year-over-year to $5.9 million in Q4 2025; TTM through Dec 2025 was $57.2 million, a 99.28% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 99.93% from the prior year.
  • Non-Current Assets fell to $5.9 million in Q4 2025 per IVA's latest filing, from $7.0 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $9.0 billion in Q2 2022 and bottomed at $5.9 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $20.8 million (2023), against an average of $3.1 billion.
  • Across the five-year window, Non-Current Assets surged 103703.96% in 2021 and tumbled 99.93% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $7.3 billion in 2021, then plunged by 99.87% to $9.8 million in 2022, then soared by 134.27% to $23.0 million in 2023, then soared by 34548.63% to $8.0 billion in 2024, then tumbled by 99.93% to $5.9 million in 2025.
  • Per Business Quant, the three latest IVA Non-Current Assets figures stand at $5.9 million (Q4 2025), $7.0 billion (Q2 2025), and $8.0 billion (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Inventiva 842.48 Mn 842.48 Mn - 5.87 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.87 Mn
Jun 30, 2025 6.95 Bn
Dec 31, 2024 7.97 Bn
Jun 30, 2024 18.54 Mn
Dec 31, 2023 22.99 Mn
Dec 31, 2022 9.82 Mn
Jun 30, 2022 9.03 Bn
Dec 31, 2021 7.33 Bn
Jun 30, 2021 8.89 Mn
Mar 31, 2021 8.21 Mn
Dec 31, 2020 7.06 Mn
Jun 30, 2020 9.42 Mn
Dec 31, 2019 8.95 Mn
Dec 31, 2018 9.33 Mn